PTCy platform for GVHD prophylaxis in matched donor allos dissect GVHD from GVL producing low cGVHD rates. Yet, aGVHD can be a problem which is abrogated by combining Tac+MMF from d+5. Ongoing phase 3 trial results awaited but it seems we are on a roll.
413 followers
2,616 followers
410 followers
RT @Colombianne: PT-Cy + 2 inmunosuppressive drugs better that PT-Cy alone for reduction of #cGVHD. #AlloSCT 🤔 Post-transplant cyclophosph…
2,930 followers
RT @Colombianne: PT-Cy + 2 inmunosuppressive drugs better that PT-Cy alone for reduction of #cGVHD. #AlloSCT 🤔 Post-transplant cyclophosph…